Literature DB >> 21619897

Acridine derivatives as anti-BVDV agents.

Michele Tonelli1, Gerolamo Vettoretti, Bruno Tasso, Federica Novelli, Vito Boido, Fabio Sparatore, Bernardetta Busonera, Aicha Ouhtit, Pamela Farci, Sylvain Blois, Gabriele Giliberti, Paolo La Colla.   

Abstract

Twenty-six 9-aminoacridine derivatives were evaluated in cell-based assays for cytotoxicity and antiviral activity against a panel of 10 RNA and DNA viruses. While seven compounds (9, 10, 14, 19, 21, 22, 24) did not affect any virus and two (6, 11) were moderately active against CVB-5 or Reo-1, 17 compounds exhibited a marked specific activity against BVDV, prototype of pestiviruses which are responsible for severe diseases of livestock. Most anti-BVDV agents showed EC(50) values in the range 0.1-8 μM, thus comparing favorably with the reference drugs ribavirine and NM 108. Some compounds, particularly those bearing a quinolizidinylalkyl side chain, displayed pronounced cytotoxicity. Further studies are warranted in order to achieve still better anti-BVDV agents, and to explore the potential antiproliferative activity of this kind of compounds.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21619897     DOI: 10.1016/j.antiviral.2011.05.005

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  6 in total

1.  Primary anti-proliferative activity evaluation of 1-(quinolizidin-1'-yl)methyl- and 1-(ω-tert-amino)alkyl-substituted 2-phenyl-, 2-benzyl- and 2-[(benzotriazol-1/2-yl)methyl]benzimidazoles on human cancer cell lines.

Authors:  Michele Tonelli; Bruno Tasso; Lorenzo Mina; Giuseppe Paglietti; Vito Boido; Fabio Sparatore
Journal:  Mol Divers       Date:  2013-04-13       Impact factor: 2.943

2.  Antiviral effects of nisin, lysozyme, lactoferrin and their mixtures against bovine viral diarrhoea virus.

Authors:  Joanna Małaczewska; Edyta Kaczorek-Łukowska; Roman Wójcik; Andrzej Krzysztof Siwicki
Journal:  BMC Vet Res       Date:  2019-09-05       Impact factor: 2.741

3.  Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus.

Authors:  Michele Tonelli; Lieve Naesens; Sabrina Gazzarrini; Matteo Santucci; Elena Cichero; Bruno Tasso; Anna Moroni; Maria Paola Costi; Roberta Loddo
Journal:  Eur J Med Chem       Date:  2017-04-27       Impact factor: 6.514

4.  Crystal structure, Hirshfeld surface and frontier mol-ecular orbital analysis of 10-benzyl-9-(4-hydroxy-3-meth-oxy-phen-yl)-3,3,6,6-tetra-methyl-3,4,6,7,9,10-hexa-hydro-acridine-1,8(2H,5H)-dione.

Authors:  V Sughanya; B Loganathan; D Praveenkumar; J Ayyappan; M L Sundararajan; A Prabhakaran; A Dhandapani; N Suresh Babu
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2022-07-14

5.  The structure of 9-(3-bromo-6-chloro-2-hy-droxy-phen-yl)-10-(2-hy-droxy-ethyl)-3,6-diphenyl-3,4,5,6,7,9-hexa-hydro-2H-acridine-1,8-dione.

Authors:  Antar A Abdelhamid; Farouq E Hawaiz; Alaa F Mohamed; Shaaban K Mohamed; Jim Simpson
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-08-14

6.  Synthesis of novel cytotoxic tetracyclic acridone derivatives and study of their molecular docking, ADMET, QSAR, bioactivity and protein binding properties.

Authors:  Rajkumar Veligeti; Rajesh Bagepalli Madhu; Jayashree Anireddy; Visweswara Rao Pasupuleti; Vijaya Kumar Reddy Avula; Krishna S Ethiraj; Srinivas Uppalanchi; Sivaprasad Kasturi; Yogeeswari Perumal; Hasitha Shilpa Anantaraju; Naveen Polkam; Mallilkarjuna Reddy Guda; Swetha Vallela; Grigory Vasilievich Zyryanov
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.